Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs

References

• HerbstRSHeymachJVLippmanSMMolecular origins of cancer lung cancerN Engl J Med20083591367138018815398
   PubMed Web of Science ®Google Scholar
• GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer200221485811902585
   PubMed Web of Science ®Google Scholar
• CitronMLBerryDACirrincioneCRandomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/cancer and leukemia group B trial 9741J Clin Oncol20032181431143912668651
   PubMed Web of Science ®Google Scholar
• YardleyDADrug resistance and the role of combination chemotherapy in improving patient outcomesInt J Breast Cancer2013201313741423864953
   PubMedGoogle Scholar
• DreicerRManolaJRothBJPhase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urotheliumCancer200410081639164515073851
   PubMed Web of Science ®Google Scholar
• du BoisALückHJMeierWArbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study GroupA randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancerJ Natl Cancer Inst200395171320132912953086
   PubMed Web of Science ®Google Scholar
• Pujade-LauraineEWagnerUAavall-LundqvistEPegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapseJ Clin Oncol201028203323332920498395
   PubMed Web of Science ®Google Scholar
• ChenAMZhangMWeiDCo-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cellsSmall20095232673267719780069
   PubMed Web of Science ®Google Scholar
• NardoneGRoccoAVairaDExpression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesisJ Pathol2004202330531214991895
   PubMedGoogle Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• GamboaJMLeongKWIn vitro and in vivo models for the study of oral delivery of nanoparticlesAdv Drug Deliv Rev201365680081023415952
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• SahaKAgastiSSKimCLiXRotelloVMGold nanoparticles in chemical and biological sensingChem Rev201211252739277922295941
   PubMed Web of Science ®Google Scholar
• ZhangYChanHFLeongKWAdvanced materials and processing for drug delivery: the past and the futureAdv Drug Deliv Rev201365110412023088863
   PubMed Web of Science ®Google Scholar
• HuCMAryalSZhangLNanoparticle-assisted combination therapies for effective cancer treatmentTher Deliv20101232333422816135
   PubMedGoogle Scholar
• KhanMOngZYWiradharmaNAttiaABYangYYAdvanced materials for co-delivery of drugs and genes in cancer therapyAdv Healthc Mater20121437339223184770
   PubMed Web of Science ®Google Scholar
• LeeJHNanACombination drug delivery approaches in metastatic breast cancerJ Drug Deliv2012201291537522619725
   PubMedGoogle Scholar
• MinkoTNanotechnology and drug resistanceAdv Drug Deliv Rev20136513–141665166624177352
   PubMedGoogle Scholar
• WangYGaoSYeWHYoonHSYangYYCo-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymerNat Mater200651079179616998471
   PubMed Web of Science ®Google Scholar
• ChenWYuanYChengDChenJWangLShuaiXCo-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapySmall201410132678268724668891
   PubMed Web of Science ®Google Scholar
• MengHLiongMXiaTEngineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell lineACS Nano2010484539455020731437
   PubMed Web of Science ®Google Scholar
• XiongXBLavasanifarATraceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicinACS Nano2011565202521321627074
   PubMed Web of Science ®Google Scholar
• ZhuCJungSLuoSCo-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymersBiomaterials20103182408241619963269
   PubMed Web of Science ®Google Scholar
• GidwaniBVyasAA comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugsBiomed Res Int2015201519826826582104
   PubMed Web of Science ®Google Scholar
• MelletCOFernándezJMGBenitoJMCyclodextrin-based gene delivery systemsChem Soc Rev20114031586160821042619
   PubMed Web of Science ®Google Scholar
• O’MahonyAMOgierJDarcyRCryanJFO’DriscollCMCationic and PEGylated amphiphilic cyclodextrins: co-formulation opportunities for neuronal siRNA deliveryPLoS One201386e6641323805220
   PubMedGoogle Scholar
• SaadMGarbuzenkoOBMinkoTCo-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancerNanomedicine (Lond)20083676177619025451
   PubMed Web of Science ®Google Scholar
• ProbstCEZrazhevskiyPBagalkotVGaoXQuantum dots as a platform for nanoparticle drug delivery vehicle designAdv Drug Deliv Rev201365570371823000745
   PubMed Web of Science ®Google Scholar
• SmithAMDuanHMohsAMNieSBioconjugated quantum dots for in vivo molecular and cellular imagingAdv Drug Deliv Rev200860111226124018495291
   PubMed Web of Science ®Google Scholar
• BijuVItohTIshikawaMDelivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imagingChem Soc Rev20103983031305620508886
   PubMed Web of Science ®Google Scholar
• ZrazhevskiyPGaoXMultifunctional quantum dots for personalized medicineNano Today20094541442820161004
   PubMed Web of Science ®Google Scholar
• ZrazhevskiyPSenaMGaoXDesigning multifunctional quantum dots for bioimaging, detection, and drug deliveryChem Soc Rev201039114326435420697629
   PubMed Web of Science ®Google Scholar
• LiJMZhaoMXSuHMultifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imagingBiomaterials201132317978798721784514
   PubMed Web of Science ®Google Scholar
• ZhaoMXLiJMDuLTargeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with beta-cyclodextrin coupled to amino acidsChemistry201117185171517921465588
   PubMedGoogle Scholar
• ZhaoMXXiaQFengXDSynthesis, biocompatibility and cell labeling of L-arginine-functional beta-cyclodextrin-modified quantum dot probesBiomaterials201031154401440820189641
   PubMedGoogle Scholar
• HuangHTangGWangQTwo novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-beta-cyclodextrin or (2-hydroxypropyl)-gamma-cyclodextrinChem Commun20062223822384
   Google Scholar
• CiardielloFInhibition of bcl-2 as cancer therapyAnn Oncol200213450150212056698
   PubMedGoogle Scholar
• AgüerosMRuiz-GatónLVauthierCCombined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxelEur J Pharm Sci200938440541319765652
   PubMed Web of Science ®Google Scholar
• MonnaertVBetbederDFenartLEffects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrierJ Pharmacol Exp Ther200431131115112015280439
   PubMedGoogle Scholar
• UtsukiTBremaHPithabJPotentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl-α-cyclodextrinJ Control Release1996403251260
   Google Scholar